Worth a closer look
- Open-market purchase with their own money (Form 4 code P), not a grant or option exercise.
- Their first purchase here in our data, after 4 sales.
Reasons for caution
- Other insiders sold $9.1M in the same 90 days, more than was bought (64% of it pre-planned).
- Similar past buys beat the S&P 500 only 35% of the time (68 cases); the typical one trailed it by 3.0%.
What happened after this filing
Insider Twins: past buys with the same traits
2 insiders buying · incl. CEO or CFO · $1M+ · stock down 20%+ in 3 months
GLPI Mar 18, 2020 +123.8% vs S&PSMMT May 14, 2021 +39.2% vs S&POPK Nov 10, 2020 +36.7% vs S&PNFE Mar 13, 2025 -71.8% vs S&PHLLY Aug 18, 2022 -54.4% vs S&PCVNA Apr 28, 2022 -53.2% vs S&PWhat we couldn't check
- Why they traded. Filings don't say, and we don't guess.
- Company news after the filing, and any private terms.
Enrico Digirolomo (a director) bought $223K of COHR at about $222.88 on Nov 10, 2026, reported to the SEC on Nov 12, 2026. Buys like this beat the S&P 500 35% of the time since 2020, against 46% for all insider buys. We found 2 points that make it worth a closer look and 2 reasons for caution. History, not a prediction.
Following. We'll keep this page updated; see everything you follow. Want an email when the 30 and 90-day results land? Use the COHR alerts below.
Get this week's insider report
The week's biggest insider buys, every new cluster buy and the stocks to watch, in one printable PDF. Plus the free Monday email.
Check your inbox to confirm, so you get next week's report too.
Written by fixed rules from SEC filings and our measured history, not by an AI model. Public data only. History, not a prediction, and not investment advice.